Similarly, in breast cancer, TLR5 activation in vitro inhibited tumor cell proliferation and colony formation by decreasing cyclin B1, cyclin D1 and cyclin E2 expression and increasing CDK inhibitor p27. This evidence concerns the gene TLR5 and neoplasm.